International journal of surgery (London, England)
Hepatic arterial infusion chemotherapy plus sintilimab as conversion therapy for locally advanced hepatocellular carcinoma: a single-center phase II trial.
Yangxun Pan, Xiaohui Wang, Chuan Peng, Jing Zhao, Shixun Lu, Chao Zhang, Juncheng Wang, Yizhen Fu, Zhongguo Zhou, Minshan Chen, Yaojun Zhang, Li Xu
Published: 202610.1097/JS9.0000000000004692
Abstract
INTRODUCTION: Patients with locally advanced hepatocellular carcinoma (aHCC) who have macroscopic vascular invasion typically have a poor prognosis. As the understanding of interventional therapy evolves, the conversion therapy strategy based on inte…
Preview only. Read the full abstract at the source